Expanded Accessibility is a potential pathway for a affected individual with a significant or promptly life-threatening sickness or condition to gain entry to an investigational clinical solution (drug, biologic, or healthcare system) for remedy beyond medical trials when no equivalent or satisfactory choice therapy solutions are available.Inside a